Uptake of 11C-choline in mouse atherosclerotic plaques

J Nucl Med. 2010 May;51(5):798-802. doi: 10.2967/jnumed.109.071704. Epub 2010 Apr 15.

Abstract

The purpose of this study was to explore the feasibility of (11)C-choline in the assessment of the degree of inflammation in atherosclerotic plaques.

Methods: Uptake of (11)C-choline was studied ex vivo in tissue samples and aortic sections excised from 6 atherosclerotic mice deficient for both low-density lipoprotein receptor and apolipoprotein B48 (LDLR(-/-)ApoB(100/100)) and 5 control mice. The autoradiographs were compared with the immunohistology of the arterial sites.

Results: The uptake of (11)C-choline (percentage of the injected activity per gram of tissue) in the atherosclerotic aortas of the LDLR(-/-)ApoB(100/100) mice was significantly higher (1.9-fold, P = 0.0016) than that in the aortas of the control mice. The autoradiography analysis showed significantly higher uptake of (11)C-choline in the plaques than in healthy vessel wall (mean ratio, 2.3 +/- 0.6; P = 0.014), prominently in inflamed plaques, compared with noninflamed plaque areas.

Conclusion: We observed a high (11)C-choline uptake in the aortic plaques of atherosclerotic mice. Our data suggest that macrophages may be responsible for the uptake of (11)C-choline in the plaques.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apolipoproteins B / genetics
  • Atherosclerosis / diagnostic imaging*
  • Atherosclerosis / genetics
  • Atherosclerosis / metabolism*
  • Choline / pharmacokinetics*
  • Cryopreservation
  • Immunohistochemistry
  • Inflammation / diagnostic imaging
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Radionuclide Imaging
  • Radiopharmaceuticals / pharmacokinetics*
  • Receptors, LDL / genetics
  • Tissue Distribution

Substances

  • Apolipoproteins B
  • Radiopharmaceuticals
  • Receptors, LDL
  • Choline